drugset / Trial / NCT03177824

Sildenafil Citrate for Treatment of Growth-restricted Fetuses

NCT03177824

Phase 3 Unknown 60 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to assess the effect of Sildenafil citrate therapy on neonatal outcomes in women with fetal growth restriction.

Timeline

Start
2017-03-30
Primary completion
2017-09-30
Completion
2017-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg